MINNEAPOLIS--(BUSINESS WIRE)--Today, TripleTree released a new research report, Changing Care Management Models in Dual Eligible Populations, an assessment of the $300 billion being spent caring for the nine million Medicare and Medicaid jointly eligible consumers in the United States. These “duals” are typically low-income, elderly, or disabled persons who qualify for both Medicare and Medicaid programs, and caring for them has become an unsustainable cost burden for the U.S. economy.
This report will assess the broad dual eligible market opportunity for healthcare innovators, and how some commercial payers are aligning their businesses to better manage care across the dual eligible population. It also identifies some of the technology and services vendors with innovative solutions for improving care coordination and care delivery for duals.
"This is the most recent in a series of reports our team has published on areas related to duals including Health Insurance Exchanges, Post-Acute Care, Innovations in Senior Care and ACO Enablement. With billions of medical spending shifting to managed care companies, there is no doubt that the dual eligible population represents tremendous revenue upside for health plans. Moreover, dual eligible beneficiaries stand to benefit from better care coordination and new approaches to care management, and the states too will benefit if savings are realized as current spending on health and human services is not sustainable,” said Chris Hoffmann, Senior Director and Chief Marketing Officer at TripleTree. “While the shift of the dual population into capitated programs will ramp more slowly than first anticipated, the lag will afford the managed care plans opportunities to retool their capabilities in support of a population that has often multiple and complex care needs. In the end, this will benefit participants, providers, the states and federal government who are seeking better, more affordable approaches to managing this complex population.”
TripleTree is an independent merchant bank focused on mergers and acquisitions, financial restructuring, and principal investing services. Since 1997, the firm has advised and invested in some of the most innovative, high-growth businesses in healthcare.